| Zylexa Pharma Ltd. | UK | Inquire | ||
|---|---|---|---|---|
![]() |
+44 (845) 299-6009/ | |||
![]() |
sales@zylexa-pharma.com,enquiries@zylexa-pharma.com | |||
| Chemical manufacturer | ||||
| Name | 1H-Imidazole-5-Carbohydrazide |
|---|---|
| Synonyms | 5-Imidazolecarboxylic Acid, Hydrazide; Aids-058587; Aids058587 |
| Molecular Structure | ![]() |
| Molecular Formula | C4H6N4O |
| Molecular Weight | 126.12 |
| CAS Registry Number | 18329-78-7 |
| SMILES | C1=C(C(NN)=O)[NH]C=N1 |
| InChI | 1S/C4H6N4O/c5-8-4(9)3-1-6-2-7-3/h1-2H,5H2,(H,6,7)(H,8,9) |
| InChIKey | FYMACJSAHLBMHV-UHFFFAOYSA-N |
| Density | 1.425g/cm3 (Cal.) |
|---|---|
| SDS | Available |
|---|---|
| (1) | Philip Prathipati, Ngai Ling Ma* and Thomas H. Keller. Global Bayesian Models for the Prioritization of Antitubercular Agents, J. Chem. Inf. Model., 2008, 48 (12), pp 2362–2370 |
|---|---|
| Market Analysis Reports |
| List of Reports Available for 1H-Imidazole-5-Carbohydrazide |